Tokyo, Japan

Kuniaki Nerome


Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 32(Granted Patents)


Company Filing History:


Years Active: 1989-1993

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kuniaki Nerome: Innovator in Immunogen and Vaccine Development

Introduction

Kuniaki Nerome is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of immunology, particularly in the development of innovative vaccines and immunogen compositions. With a total of 2 patents, his work has the potential to impact public health positively.

Latest Patents

Nerome's latest patents include a stable immunogen composition for oral administration and a novel influenza vaccine. The stable immunogen composition is designed for oral use and consists of a dried spherical form that includes an immunogen capable of immunizing humans or animals, combined with gelatin of specific molecular weight and jelly strength. This formulation is enteric, enhancing its effectiveness. The influenza vaccine patent describes a complex of HANA antigen and an MDP derivative, which is prepared by mixing the antigen with the derivative in a suitable medium. This innovative vaccine boasts improved immunogenicity compared to conventional vaccines, as it mimics the natural influenza virus particle's size and shape.

Career Highlights

Throughout his career, Kuniaki Nerome has worked with esteemed organizations such as the National Institute of Health and Daiichi Seiyaku Co., Ltd. His experience in these institutions has allowed him to refine his expertise in immunology and vaccine development.

Collaborations

Nerome has collaborated with notable colleagues, including Akira Oya and Kunio Ohkuma. These partnerships have contributed to the advancement of his research and innovations in the field.

Conclusion

Kuniaki Nerome's contributions to immunogen and vaccine development highlight his role as a key innovator in the field. His patents reflect a commitment to enhancing public health through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…